|
1
|
Blume-Jensen P and Hunter T: Oncogenic
kinase signalling. Nature. 411:355–365. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Klein R: Excitatory Eph receptors and
adhesive ephrin ligands. Curr Opin Cell Biol. 13:196–203. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Noren NK and Pasquale EB: Eph
receptor-ephrin bidirectional signals that target Ras and Rho
proteins. Cell Signal. 16:655–666. 2004. View Article : Google Scholar
|
|
4
|
Wilkinson DG: Eph receptors and ephrins:
regulators of guidance and assembly. Int Rev Cytol. 196:177–244.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cooke JE and Moens CB: Boundary formation
in the hindbrain: Eph only it were simple. Trends Neurosci.
25:260–267. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Krull CE, Lansford R, Gale NW, et al:
Interactions of Eph-related receptors and ligands confer
rostrocaudal pattern to trunk neural crest migration. Curr Biol.
7:571–580. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gale NW, Holland SJ, Valenzuela DM, et al:
Eph receptors and ligands comprise two major specificity subclasses
and are reciprocally compartmentalized during embryogenesis.
Neuron. 17:9–19. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Davy A and Robbins SM: Ephrin-A5 modulates
cell adhesion and morphology in an integrin-dependent manner. EMBO
J. 19:5396–5405. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lawrenson ID, Wimmer-Kleikamp SH, Lock P,
et al: Ephrin-A5 induces rounding, blebbing and de-adhesion of
EphA3-expressing 293T and melanoma cells by CrkII and Rho-mediated
signalling. J Cell Sci. 115:1059–1072. 2002.PubMed/NCBI
|
|
10
|
Wang J, Dong Y, Wang X, et al: Expression
of EphA1 in gastric carcinomas is associated with metastasis and
survival. Oncol Rep. 24:1577–1584. 2010.PubMed/NCBI
|
|
11
|
Nakamura R, Kataoka H, Sato N, et al:
EPHA2/EFNA1 expression in human gastric cancer. Cancer Sci.
96:42–47. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yuan W, Chen Z, Wu S, et al: Expression of
EphA2 and E-cadherin in gastric cancer: correlated with tumor
progression and lymphogenous metastasis. Pathol Oncol Res.
15:473–478. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang J, Li G, Ma H, et al: Differential
expression of EphA7 receptor tyrosine kinase in gastric carcinoma.
Hum Pathol. 38:1649–1656. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hafner C, Schmitz G, Meyer S, et al:
Differential gene expression of Eph receptors and ephrins in benign
human tissues and cancers. Clin Chem. 50:490–499. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wimmer-Kleikamp SH and Lackmann M:
Eph-modulated cell morphology, adhesion and motility in
carcinogenesis. IUBMB Life. 57:421–431. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bae HJ, Song JH, Noh JH, et al: Low
frequency mutation of the Ephrin receptor A3 gene in hepatocellular
carcinoma. Neoplasma. 56:331–334. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xi HQ and Zhao P: Clinicopathological
significance and prognostic value of EphA3 and CD133 expression in
colorectal carcinoma. J Clin Pathol. 64:498–503. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chu D, Li Y, Wang W, et al: High level of
Notch1 protein is associated with poor overall survival in
colorectal cancer. Ann Surg Oncol. 17:1337–1342. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou L, Wang DS, Li QJ, Sun W, Zhang Y and
Dou KF: Downregulation of the Notch signaling pathway inhibits
hepatocellular carcinoma cell invasion by inactivation of matrix
metalloproteinase-2 and -9 and vascular endothelial growth factor.
Oncol Rep. 28:874–882. 2012.
|
|
20
|
Raspollini MR, Amunni G, Villanucci A,
Baroni G, Boddi V and Taddei GL: Prognostic significance of
microvessel density and vascular endothelial growth factor
expression in advanced ovarian serous carcinoma. Int J Gynecol
Cancer. 14:815–823. 2004. View Article : Google Scholar
|
|
21
|
Dodelet VC and Pasquale EB: Eph receptors
and ephrin ligands: embryogenesis to tumorigenesis. Oncogene.
19:5614–5619. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Clevers H and Batlle E: EphB/EphrinB
receptors and Wnt signaling in colorectal cancer. Cancer Res.
66:2–5. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nakamoto M and Bergemann AD: Diverse roles
for the Eph family of receptor tyrosine kinases in carcinogenesis.
Microsc Res Tech. 59:58–67. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Brantley-Sieders D, Schmidt S, Parker M
and Chen J: Eph receptor tyrosine kinases in tumor and tumor
microenvironment. Curr Pharm Des. 10:3431–3442. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Héroult M, Schaffner F and Augustin HG:
Eph receptor and ephrin ligand-mediated interactions during
angiogenesis and tumor progression. Exp Cell Res. 312:642–650.
2006.PubMed/NCBI
|
|
26
|
Xi HQ, Wu XS, Wei B and Chen L: Aberrant
expression of EphA3 in gastric carcinoma: correlation with tumor
angiogenesis and survival. J Gastroenterol. 47:785–794. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Davies H, Hunter C, Smith R, et al:
Somatic mutations of the protein kinase gene family in human lung
cancer. Cancer Res. 65:7591–7595. 2005.PubMed/NCBI
|
|
28
|
Bardelli A, Parsons DW, Silliman N, et al:
Mutational analysis of the tyrosine kinome in colorectal cancers.
Science. 300:9492003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bonifaci N, Gorski B, Masojc B, et al:
Exploring the link between germline and somatic genetic alterations
in breast carcinogenesis. PLoS One. 5:e140782010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee JS and Thorgeirsson SS: Comparative
and integrative functional genomics of HCC. Oncogene. 25:3801–3809.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Boyd AW, Ward LD, Wicks IP, et al:
Isolation and characterization of a novel receptor-type protein
tyrosine kinase (hek) from a human pre-B cell line. J Biol Chem.
267:3262–3267. 1992.PubMed/NCBI
|
|
32
|
Wicks IP, Wilkinson D, Salvaris E and Boyd
AW: Molecular cloning of HEK, the gene encoding a receptor tyrosine
kinase expressed by human lymphoid tumor cell lines. Proc Natl Acad
Sci USA. 89:1611–1615. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dottori M, Down M, Hüttmann A, Fitzpatrick
DR and Boyd AW: Cloning and characterization of EphA3 (Hek) gene
promoter: DNA methylation regulates expression in hematopoietic
tumor cells. Blood. 94:2477–2486. 1999.PubMed/NCBI
|
|
34
|
Fox BP, Tabone CJ and Kandpal RP:
Potential clinical relevance of Eph receptors and ephrin ligands
expressed in prostate carcinoma cell lines. Biochem Biophys Res
Commun. 342:1263–1272. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fidler IJ: The pathogenesis of cancer
metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev
Cancer. 3:453–458. 2003.
|
|
36
|
Weiss L: Metastasis of cancer: a
conceptual history from antiquity to the 1990s. Cancer Metastasis
Rev. 19:I–XI. 193–383. 2000.PubMed/NCBI
|
|
37
|
Wey JS, Fan F, Gray MJ, et al: Vascular
endothelial growth factor receptor-1 promotes migration and
invasion in pancreatic carcinoma cell lines. Cancer. 104:427–438.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Takahashi Y, Kitadai Y, Bucana CD, Cleary
KR and Ellis LM: Expression of vascular endothelial growth factor
and its receptor, KDR, correlates with vascularity, metastasis, and
proliferation of human colon cancer. Cancer Res. 55:3964–3968.
1995.PubMed/NCBI
|
|
39
|
Folkman J: What is the evidence that
tumors are angiogenesis dependent? J Natl Cancer Inst. 82:4–6.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Joo YE, Sohn YH, Lee WS, et al: Expression
of vascular endothelial growth factor and p53 in pancreatic
carcinomas. Korean J Intern Med. 17:153–159. 2002.PubMed/NCBI
|
|
41
|
Zeng H, Datta K, Neid M, Li J, Parangi S
and Mukhopadhyay D: Requirement of different signaling pathways
mediated by insulin-like growth factor-I receptor for
proliferation, invasion, and VPF/VEGF expression in a pancreatic
carcinoma cell line. Biochem Biophys Res Commun. 302:46–55. 2003.
View Article : Google Scholar : PubMed/NCBI
|
